287 research outputs found

    Enterprise Budgets for Livestock Businesses that Use National Forest Grazing Land

    Get PDF
    Cow-calf and sheep enterprise inputs, production, costs, and returns are estimated for ranches with Forest Service grazing permits using 1982 as a base year. Budgets represent different cow and sheep herd sizes in National Forests and national Grasslands of United States.Beef cows, sheep costs and returns, Federal rangeland, Livestock Production/Industries,

    Strategic Habitat Conservation for Declining Grassland Wildlife Populations in the Oaks and Prairies Joint Venture

    Get PDF
    Degradation and conversion of functioning grassland ecosystems in North America has driven significant declines in grassland wildlife populations across multiple taxa. In an effort to address declines in the grasslands of Oklahoma and Texas, a number of governmental agencies and Non-Governmental Organizations have partnered to form the Oaks and Prairies Joint Venture (OPJV) to more strategically and collaboratively deliver conservation actions in this region. With northern bobwhite (Colinus virginianus) as the flagship species, OPJV has worked to implement a fully integrated Strategic Habitat Conservation framework that works at multiple scales to conduct biological planning, landscape conservation design, habitat tracking and population monitoring in support of conservation efforts aimed at restoring not just northern bobwhite, but a variety of bird and pollinator species that depend on healthy grasslands. The signature conservation delivery program of this effort was the Grassland Restoration Incentive Program (GRIP) which has improved habitat for grassland wildlife on over 24,300 hectares of working lands in focus areas throughout the OPJV geography since it was created in 2013. The Grassland Restoration Incentive Program was accompanied by a full complement of conservation delivery programs that support prescribed burning associations and other landowner cooperatives, utilize market-based conservation delivery strategies, and implement strategic outreach and communications. The conservation efforts were supported by over 4,500 point counts annually in National Bobwhite Conservation Initiative Coordination Implementation Program focal areas as well as 7 focal regions, each comprising clusters of 2-8 counties. Combining the efforts of multiple partners ties the range-wide population and habitat objectives with on-the-ground conservation actions for quail, other grassland birds, butterflies, and grassland pollinators

    The Effects on the Femoral Cortex of a 24 Month Treatment Compared to an 18 Month Treatment with Teriparatide: A Multi-Trial Retrospective Analysis.

    Get PDF
    BACKGROUND: Teriparatide (TPTD) is an anabolic agent indicated for the treatment of severely osteoporotic patients who are at high risk of fragility fractures. The originally approved duration of TPTD treatment in several regions, including Europe, was 18 months. However, studies of areal bone mineral density (aBMD) showed additional benefit when treatment is continued beyond 18 months, and the drug is currently licenced for 24 months. Improvements in cortical structure at the proximal femur have already been shown in patients given TPTD for 24 months using quantitative computed tomography (QCT). Here, we investigate whether cortical and endocortical trabecular changes differ between an 18- and 24-month treatment. METHODS: Since an 18- versus 24-month TPTD study using QCT has not been conducted, we studied combined QCT data from four previous clinical trials. Combined femoral QCT data from three 18-month TPTD studies ('18-month group') were compared with data from a fourth 24-month trial ('24-month group'). Cortical parameters were measured over the entire proximal femur which allowed for a comparison of the mean changes as well as a visual comparison of the colour maps of changes after 18 and 24 months TPTD. RESULTS: For both the combined 18-month group and the 24-month group, overall cortical thickness and endocortical trabecular density increased, while overall cortical bone mineral density decreased. While the changes in the 24-month group were of greater magnitude compared to the 18-month group, the differences were only significant for the endocortical trabecular density (ECTD), corrected for age, weight, femoral neck T-score, total hip T-score and the baseline mean ECTD. CONCLUSION: Although the combination of data from different clinical trials is not optimal, these data support the concept that the duration of TPTD in the 18-24 month phase is of clinical relevance when considering improvement in hip structure.This study was funded by Eli Lilly. TW, GMT, AHG and KESP received research grants from Eli Lilly. KESP is also funded by the Cambridge NIHR Biomedical research Centre. The Evelyn Trust funded GMT. The funders had no role in study design, data analysis or decision to publish, but were involved in collection of data and had the chance to review the manuscript once written.This is the final version of the article. It first appeared from PLOS via http://dx.doi.org/10.1371/journal.pone.014772

    Quantitative 3D analysis of bone in hip osteoarthritis using clinical computed tomography.

    Get PDF
    OBJECTIVE: To assess the relationship between proximal femoral cortical bone thickness and radiological hip osteoarthritis using quantitative 3D analysis of clinical computed tomography (CT) data. METHODS: Image analysis was performed on clinical CT imaging data from 203 female volunteers with a technique called cortical bone mapping (CBM). Colour thickness maps were created for each proximal femur. Statistical parametric mapping was performed to identify statistically significant differences in cortical bone thickness that corresponded with the severity of radiological hip osteoarthritis. Kellgren and Lawrence (K&L) grade, minimum joint space width (JSW) and a novel CT-based osteophyte score were also blindly assessed from the CT data. RESULTS: For each increase in K&L grade, cortical thickness increased by up to 25Β % in distinct areas of the superolateral femoral head-neck junction and superior subchondral bone plate. For increasing severity of CT osteophytes, the increase in cortical thickness was more circumferential, involving a wider portion of the head-neck junction, with up to a 7Β % increase in cortical thickness per increment in score. Results were not significant for minimum JSW. CONCLUSIONS: These findings indicate that quantitative 3D analysis of the proximal femur can identify changes in cortical bone thickness relevant to structural hip osteoarthritis. KEY POINTS: β€’ CT is being increasingly used to assess bony involvement in osteoarthritis β€’ CBM provides accurate and reliable quantitative analysis of cortical bone thickness β€’ Cortical bone is thicker at the superior femoral head-neck with worse osteoarthritis β€’ Regions of increased thickness co-locate with impingement and osteophyte formation β€’ Quantitative 3D bone analysis could enable clinical disease prediction and therapy development.TT acknowledges the support of an Evelyn Trust Clinical Training Fellowship award (RG65411). KP acknowledges support of an Arthritis Research UK Research Progression award (RG66087), and the Cambridge NIHR Biomedical Research Centre (RG64245). None of the funding sources had a role in study design, data handling, writing of the report, or decision to submit the paper for publication.This is the final version of the article. It first appeared from Springer via http://dx.doi.org/10.1007/s00330-015-4048-

    Yes-Associated Protein 65 (YAP) Expands Neural Progenitors and Regulates Pax3 Expression in the Neural Plate Border Zone

    Get PDF
    Yes-associated protein 65 (YAP) contains multiple protein-protein interaction domains and functions as both a transcriptional co-activator and as a scaffolding protein. Mouse embryos lacking YAP did not survive past embryonic day 8.5 and showed signs of defective yolk sac vasculogenesis, chorioallantoic fusion, and anterior-posterior (A-P) axis elongation. Given that the YAP knockout mouse defects might be due in part to nutritional deficiencies, we sought to better characterize a role for YAP during early development using embryos that develop externally. YAP morpholino (MO)-mediated loss-of-function in both frog and fish resulted in incomplete epiboly at gastrulation and impaired axis formation, similar to the mouse phenotype. In frog, germ layer specific genes were expressed, but they were temporally delayed. YAP MO-mediated partial knockdown in frog allowed a shortened axis to form. YAP gain-of-function in Xenopus expanded the progenitor populations in the neural plate (sox2+) and neural plate border zone (pax3+), while inhibiting the expression of later markers of tissues derived from the neural plate border zone (neural crest, pre-placodal ectoderm, hatching gland), as well as epidermis and somitic muscle. YAP directly regulates pax3 expression via association with TEAD1 (N-TEF) at a highly conserved, previously undescribed, TEAD-binding site within the 5β€² regulatory region of pax3. Structure/function analyses revealed that the PDZ-binding motif of YAP contributes to the inhibition of epidermal and somitic muscle differentiation, but a complete, intact YAP protein is required for expansion of the neural plate and neural plate border zone progenitor pools. These results provide a thorough analysis of YAP mediated gene expression changes in loss- and gain-of-function experiments. Furthermore, this is the first report to use YAP structure-function analyzes to determine which portion of YAP is involved in specific gene expression changes and the first to show direct in vivo evidence of YAP's role in regulating pax3 neural crest expression

    Impacts of human hunting on spatial behavior of white-tailed deer (Odocoileus virginianus)

    Get PDF
    This study was funded by The Samuel Roberts Noble Foundation, Inc., and the Department of Wildlife, Fisheries and Aquaculture at Mississippi State University.Predators can influence populations through top-down effects, but most large predators have been extirpated from the white-tailed deer’s (Odocoileus virginianus) range. Hunters have filled this predatory role, but also can indirectly influence prey species. Indirect behavioral responses can include altered resource selection, space use, or movement patterns. Herein, we developed a controlled study that contained both temporal and spatial risk levels to assess how deer behavior changes in space relative to temporal periods of risk. Total distance travelled (m) and micro-range area (mΒ²) were calculated over two-day periods to determine the general effects of hunting season on deer spatial behavior. Generally, distance travelled, micro-range area, and exploratory behavior decreased during the course of the study, with the greatest decrease occurring during the active 16-day hunting period. Despite potential risk and disturbance from hunters, deer maintained site fidelity to previously established ranges and did not expand micro-range areas. These data indicate that deer recognize threats from humans on the landscape and adapt behavioral strategies by minimizing movement and exhibiting high residency times in well-established ranges, factors known to influence harvest susceptibility. This information can be used to assess potential impacts from hunting for management purposes, but also to test the adaptive ability of animals to risk.Publisher PDFPeer reviewe

    Targeted regeneration of bone in the osteoporotic human femur.

    Get PDF
    We have recently developed image processing techniques for measuring the cortical thicknesses of skeletal structures in vivo, with resolution surpassing that of the underlying computed tomography system. The resulting thickness maps can be analysed across cohorts by statistical parametric mapping. Applying these methods to the proximal femurs of osteoporotic women, we discover targeted and apparently synergistic effects of pharmaceutical osteoporosis therapy and habitual mechanical load in enhancing bone thickness

    Denosumab rapidly increases cortical bone in key locations of the femur: a 3D bone mapping study in women with osteoporosis.

    Get PDF
    Women with osteoporosis treated for 36 months with twice-yearly injections of denosumab sustained fewer hip fractures compared with placebo. Treatment might improve femoral bone at locations where fractures typically occur. To test this hypothesis, we used 3D cortical bone mapping of postmenopausal women with osteoporosis to investigate the timing and precise location of denosumab versus placebo effects in the hips. We analyzed clinical computed tomography scans from 80 female participants in FREEDOM, a randomized trial, wherein half of the study participants received subcutaneous denosumab 60 mg twice yearly and the others received placebo. Cortical 3D bone thickness maps of both hips were created from scans at baseline, 12, 24, and 36 months. Cortical mass surface density maps were also created for each visit. After registration of each bone to an average femur shape model followed by statistical parametric mapping, we visualized and quantified statistically significant treatment effects. The technique allowed us to pinpoint systematic differences between denosumab and control and to display the results on a 3D average femur model. Denosumab treatment led to an increase in femoral cortical mass surface density and thickness, already evident by the third injection (12 months). Overall, treatment with denosumab increased femoral cortical mass surface density by 5.4% over 3 years. One-third of the increase came from increasing cortical density, and two-thirds from increasing cortical thickness, relative to placebo. After 36 months, cortical mass surface density and thickness had increased by up to 12% at key locations such as the lateral femoral trochanter versus placebo. Most of the femoral cortex displayed a statistically significant relative difference by 36 months. Osteoporotic cortical bone responds rapidly to denosumab therapy, particularly in the hip trochanteric region. This mechanism may be involved in the robust decrease in hip fractures observed in denosumab-treated women at increased risk of fracture.This study was funded by Amgen Inc., Thousand Oaks, CA, USA. Cambridge Bone Group is supported by Arthritis Research UK, The Evelyn Trust, and Cambridge NIHR Biomedical Research Centre.This is the final version of the article. It first appeared from Wiley via http://dx.doi.org/10.1002/jbmr.232
    • …
    corecore